杭州安杰思医学科技股份有限公司 关于股东减持计划时间届满暨减持股份结果公告

Summary of Key Points Core Viewpoint - The company announced the completion of a share reduction plan by its shareholder, Suzhou Yuan Sheng Private Fund Management Partnership, which involved a total reduction of 345,816 shares, representing 0.4270% of the total share capital [1][2]. Group 1: Shareholder Holdings - Before the reduction plan, the shareholder "Xin Jian Yuan" held 3,233,835 shares, accounting for 3.9934% of the company's total share capital, with shares acquired from the company's initial public offering and through the distribution of bonus shares in 2023 [1]. Group 2: Reduction Plan Implementation - The reduction plan was disclosed on July 3, 2025, with a maximum intended reduction of 1,622,700 shares (2.0039% of total shares), including up to 809,700 shares through centralized bidding and 813,000 shares through block trading, scheduled from July 25, 2025, to October 23, 2025 [1]. - As of October 23, 2025, the shareholder successfully reduced 345,816 shares through centralized bidding, with no shares sold via block trading, concluding the reduction plan [2][3].